Eric Rondeau Selected Research

Hemolytic-Uremic Syndrome

1/2021	Shiga Toxin-Associated Hemolytic Uremic Syndrome in Adults, France, 2009-2017.
11/2020	Ockham's razor defeated: about two atypical cases of hemolytic uremic syndrome.
12/2019	Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome.
1/2018	Early Differentiation of Shiga Toxin-Associated Hemolytic Uremic Syndrome in Critically Ill Adults With Thrombotic Microangiopathy Syndromes.
5/2010	Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric Rondeau Research Topics

Disease

14	Atypical Hemolytic Uremic Syndrome 07/2022 - 11/2014
13	Thrombotic Microangiopathies 01/2020 - 12/2005
11	Renal Insufficiency (Renal Failure) 01/2022 - 05/2007
11	Proteinuria 01/2019 - 04/2002
11	Glomerulonephritis 01/2017 - 10/2003
10	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 10/2003
9	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 09/2011
9	Fibrosis (Cirrhosis) 01/2018 - 01/2004
7	Neoplasms (Cancer) 07/2022 - 09/2003
7	Kidney Diseases (Kidney Disease) 07/2022 - 01/2012
6	Chronic Renal Insufficiency 01/2022 - 02/2014
6	Thrombotic Thrombocytopenic Purpura 01/2018 - 01/2012
5	Hemolytic-Uremic Syndrome 01/2021 - 05/2010
5	Infections 01/2019 - 05/2007
5	Inflammation (Inflammations) 01/2018 - 01/2004
4	Hemolysis 01/2020 - 06/2010
4	Pre-Eclampsia (Preeclampsia) 12/2018 - 05/2010
4	Necrosis 06/2017 - 05/2013
4	Atrophy 07/2011 - 08/2008
3	Wounds and Injuries (Trauma) 12/2017 - 12/2005
3	Hypertension (High Blood Pressure) 01/2017 - 01/2012
3	acquired Thrombotic thrombocytopenic purpura 05/2016 - 01/2012
3	Disease Progression 12/2015 - 01/2012
2	Vasculitis (Vasculitides) 07/2022 - 05/2016
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2022 - 12/2015
2	Smoldering Multiple Myeloma 01/2021 - 09/2011
2	Amyloidosis 01/2021 - 01/2017
2	Rhabdomyolysis 03/2020 - 11/2005
2	Meningococcal Infections 10/2019 - 07/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 05/2016
2	Diarrhea 01/2018 - 07/2010
2	Hypoxia (Hypoxemia) 12/2017 - 10/2004
2	Hypertensive Nephropathy 12/2017 - 01/2012
2	Hypovolemia 06/2017 - 10/2012
2	Bacterial Infections (Bacterial Infection) 01/2017 - 01/2011
2	Hemorrhage 01/2017 - 11/2006
2	Thrombocytopenia (Thrombopenia) 09/2014 - 07/2010
2	Sepsis (Septicemia) 05/2013 - 04/2007
2	HELLP Syndrome 11/2010 - 06/2010
2	Diabetic Nephropathies (Diabetic Nephropathy) 09/2005 - 08/2005
1	Fatigue 05/2022
1	Polycythemia (Erythrocytosis) 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	Autosomal Dominant Polycystic Kidney (ADPKD) 03/2021
1	Multiple Myeloma 01/2021
1	Mycoses (Diseases, Fungus) 01/2021

Drug/Important Bio-Agent (IBA)

12	eculizumab FDA Link 07/2022 - 11/2014
9	Complement System Proteins (Complement)IBA 10/2021 - 05/2010
7	Complement Inactivating AgentsIBA 05/2022 - 07/2016
5	ravulizumabIBA 07/2022 - 01/2020
5	CreatinineIBA 11/2021 - 01/2012
5	VimentinIBA 11/2014 - 12/2009
4	EnzymesIBA 01/2020 - 06/2010
4	Biological ProductsIBA 12/2019 - 04/2004
4	AntibodiesIBA 05/2016 - 09/2003
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2018
3	Immunoglobulins (Immunoglobulin)IBA 03/2021 - 09/2011
3	Shiga Toxin (Shigella Toxin)IBA 01/2021 - 06/2013
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2008
3	antiglomerular basement membrane antibodyIBA 01/2017 - 06/2009
3	Metalloproteases (Metalloproteinases)IBA 05/2016 - 06/2006
3	Immunoglobulin G (IgG)IBA 05/2016 - 12/2015
3	thiamine triphosphorate (TTP)IBA 02/2014 - 06/2012
3	FibrinIBA 10/2011 - 01/2004
3	Plasminogen Activator Inhibitor 1IBA 09/2005 - 04/2002
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 07/2022 - 05/2016
2	Immunoglobulin A (IgA)IBA 01/2022 - 12/2015
2	AngiotensinsIBA 01/2018 - 10/2012
2	Transcription Factors (Transcription Factor)IBA 12/2017 - 10/2004
2	ThrombospondinsIBA 05/2016 - 06/2012
2	DisintegrinsIBA 05/2016 - 06/2012
2	Pharmaceutical PreparationsIBA 01/2016 - 05/2007
2	CateninsIBA 11/2014 - 07/2011
2	Urokinase Plasminogen Activator ReceptorsIBA 08/2014 - 01/2002
2	Rituximab (Mabthera)FDA Link 02/2014 - 01/2012
2	von Willebrand FactorIBA 02/2013 - 06/2006
2	Plasminogen Activators (Plasminogen Activator)IBA 10/2011 - 01/2004
2	VitronectinIBA 10/2011 - 01/2004
2	CalciumIBA 01/2011 - 08/2002
2	Transforming Growth Factor beta (TGF-beta)IBA 06/2009 - 10/2003
1	Ferritins (Ferritin)IBA 07/2022
1	Dacarbazine (DIC)FDA LinkGeneric 07/2022
1	avacopanIBA 07/2022
1	ElementsIBA 01/2022
1	Complement C5 (Complement 5)IBA 10/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021

Therapy/Procedure

12	Kidney Transplantation 01/2022 - 09/2003
9	Transplantation 05/2021 - 09/2003
6	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022 - 04/2016
6	Therapeutics 01/2021 - 01/2012
6	Organ Transplantation 01/2019 - 09/2003
3	Plasma Exchange 01/2018 - 07/2010
2	Drug Therapy (Chemotherapy) 07/2022 - 09/2003
2	Stem Cell Transplantation 07/2022 - 10/2003
2	Perioperative Period 12/2016 - 04/2016
2	Renal Dialysis (Hemodialysis) 01/2016 - 05/2007
1	Intermittent Renal Replacement Therapy 01/2022
1	Continuous Renal Replacement Therapy 01/2022
1	Peritoneal Dialysis 01/2021
1	Artificial Respiration (Mechanical Ventilation) 03/2020